Llwytho...
Supramolecular prodrug hydrogelator as an immune booster for checkpoint blocker–based immunotherapy
Immune checkpoint blockers (ICBs) have shown great promise at harnessing immune system to combat cancer. However, only a fraction of patients can directly benefit from the anti–programmed cell death protein 1 (aPD1) therapy, and the treatment often leads to immune-related adverse effects. In this co...
Wedi'i Gadw mewn:
| Cyhoeddwyd yn: | Sci Adv |
|---|---|
| Prif Awduron: | , , , , , , , , , , , , , |
| Fformat: | Artigo |
| Iaith: | Inglês |
| Cyhoeddwyd: |
American Association for the Advancement of Science
2020
|
| Pynciau: | |
| Mynediad Ar-lein: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7239700/ https://ncbi.nlm.nih.gov/pubmed/32490201 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1126/sciadv.aaz8985 |
| Tagiau: |
Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!
|